University of Pennsylvania Health System

Department of Ophthalmology

Ophthalmology Faculty

Faculty Overview

Brian VanderBeek, MD, MPH, MSCE

faculty photo
Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania
PPMC OR Operations Committee, Penn Medicine , Penn Presbyterian Medical Center
Penn EPIC Governance Ophthalmology Lead , Scheie Eye Institute
Vice Chair for Clinical Operations, Scheie Eye Institute, University of Pennsylvania
Department: Ophthalmology

Contact information
Scheie Eye Institute
51 N. 39th Street
Philadelphia, PA 19104
Education:
BA (Biology)
University of Michigan, School of Literature, Science & Arts, 1999.
MPH (Toxicology)
University of Michigan, School of Public Health, 2001.
MD
University of Cincinnati College of Medicine, 2005.
MSCE
University of Pennsylvania School of Medicine, 2015.
Post-Graduate Training
Intern - Internal Medicine, Christ Hospital - Cincinnati, Ohio, 2005-2006.
Ophthalmology Resident, New York Presbyterian Hospital Weill Cornell Medical College - New York, NY, 2006-2009.
Lecturer and Fellow, Retina, Uveitis, and Ocular Oncology , University of Michigan Kellogg Eye Center - Ann Arbor, MI, 2009-2011.
Certifications
American Board of Ophthalmology, 2011.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Diabetic Retinopathy
Age-related Macular Edema
Retinal Vein Occlusion

Description of Research Expertise

Epidemiology
Observational study design
Big data analysis

Selected Publications

Meer E, Bavinger JC, Yu Y, Hua P, McGeehan B, VanderBeek BL: Statin use and the risk of progression to vision threatening diabetic retinopathy. Pharmacoepidemiology and Drug Safety 31(6): 652-60, Jun 2022 Notes: Epub 2022 Mar 15.

NA: Effects of intravitreal anti-VEGF injections on renal function over the long term. Ophthalmology Times May 2022 Notes: https://www.medscape.com/viewarticle/971772?src=

Meer E, Ramakrishnan M, Whitehead G, VanderBeek BL: “Symptom Based Triage Tool in Ophthalmology” Association for Research in Vision and Ophthalmology annual meeting May 2022.

Choi D, McGeehan B, VanderBeek BL: “Evaluation of Long-Term Intravitreal Anti-Vascular Endothelial Growth (VEGF) injections on Renal Function” Association for Research in Vision and Ophthalmology annual meeting May 2022.

VanderBeek BL, Maguire MG: Phase 4 Studies on Phosphodiesterase 5 Inhibitors. JAMA Ophthalmology 140(5): 484-5, May 2022.

Cohen D, Butler NJ, Yu Y, Kempen JH, Sobrin L, VanderBeek BL: “Adherence to dual-energy x-ray absorptiometry scan recommendations and fracture risk in non-infectious uveitis patients” Association for Research in Vision and Ophthalmology annual meeting May 2022.

Meer E, Bavinger JC, Yu Y, VanderBeek BL: Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy. JAMA Ophthalmology 140(5): 529-32, May 2022.

Pradeep T, Conrady C, Yu Y, VanderBeek BL: “Association of PPI/H2 Blocker Use and Ocular Toxoplasmosis: Findings from a Large US National Database” Association for Research in Vision and Ophthalmology annual meeting May 2022.

Nadelmann J, Miller C, McGeehan B, Yu Y, VanderBeek BL. : “SGLT2 inhibitors and diabetic retinopathy progression" Association for Research in Vision and Ophthalmology annual meeting May 2022.

Scoles D, McGeehan B, VanderBeek BL : The association of stroke with central and branch retinal arterial occlusion. Eye (Lond) 36(4): 835-843, Apr 2022 Notes: Epub 2021 Apr 28.

back to top
Last updated: 06/23/2022
The Trustees of the University of Pennsylvania